Skip to content

Opus Genetics IRD Share Repurchases for Payment of Employee Taxes

Share Repurchases for Payment of Employee Taxes at other companies

Columbia Financial, Inc. logo
Columbia Financial, Inc.CLBK
$103K-20.8%
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
$8K+60.0%
GCO
GenescoGCO
$2.11M+217%
Contango Silver & Gold
 logo
Contango Silver & Gold CTGO
$0+100%
State Street logo
State StreetSTT
$85M+49.1%
Peabody Energy logo
Peabody EnergyBTU
$3.3M+313%

Other financials

Income statement

See full
Revenue$2.2M-50.6%
Operating income-$14.4M-44.7%
Net income-$65.5M-700%
EPS (diluted)-$0.75-213%

Balance sheet

See full
Cash & equivalents$60.0M+43.5%
Total debt$1.2M
Total equity-$45.8M-1,004%
Total assets$66.8M+38.7%

Cash flow

See full
Operating cash flow-$12.7M-41.5%

Valuation

See full
Market cap$307.14M+442%
Enterprise value$248.38M
P/S25.6×+21.5×

Profitability

See full
Operating margin-359.1%-68.9pp
Net margin-892.4%-12,322pp

Returns & leverage

See full
Return on equity-449.4%-2,573pp
Debt / equity0.1×
Current ratio7.1×+5.2×

Where this comes from

Reported directly by Opus Genetics in its filing.

Tagged under the XBRL concept ird:ShareRepurchasesForPaymentOfEmployeeTaxes.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's share repurchases for payment of employee taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opus Genetics's share repurchases for payment of employee taxes?
Opus Genetics (IRD) reported share repurchases for payment of employee taxes of $33K in Q1 2026.
How has Opus Genetics's share repurchases for payment of employee taxes changed year-over-year?
Opus Genetics's share repurchases for payment of employee taxes decreased by 8.3% year-over-year, from $36K to $33K.
What does share repurchases for payment of employee taxes mean?
Captures the cash used by the company to withhold and pay taxes on behalf of employees upon the vesting of equity-based compensation awards. This is a routine administrative cash outflow that effectively reduces the net number of shares issued to employees.